devhealthylife1@gmail.com

DoubleLine’s Gundlach cuts gold exposure to 10% after ‘nosebleed’ rally

DoubleLine’s Gundlach cuts gold exposure to 10% after ‘nosebleed’ rally

DoubleLine Capital CEO Jeffrey Gundlach is dialing back his exposure to gold after the precious metal’s powerful run this year, saying it’s time for investors to rebalance as the price climbs to “nosebleed levels.” Gundlach, whose firm managed about $95 billion at the end of 2024, had recommended a 25% gold position in mid-September. Since…

Read More
ServiceNow (NOW) earnings Q3 2025

ServiceNow (NOW) earnings Q3 2025

Bill McDermott, chief executive officer of ServiceNow Inc., during the Allen & Co. Media and Technology Conference in Sun Valley, Idaho, US, on Thursday, July 10, 2025. David Paul Morris | Bloomberg | Getty Images ServiceNow reported third-quarter results on Wednesday that blew past Wall Street’s estimates, with the company also approving a five-for-one stock…

Read More
Northside CIO Jim DeWolfe says investors are turning to alternatives as 60/40 portfolio falls short

Northside CIO Jim DeWolfe says investors are turning to alternatives as 60/40 portfolio falls short

The traditional 60/40 portfolio of stocks and bonds no longer delivers the returns investors need, pushing more money into alternatives such as hedge funds and private credit, according to Jim DeWolfe, co-founder and chief investment officer at Northside Capital. Over the past 35 years, the classic 60/40 mix of global stocks and bonds has generated…

Read More
Blackrock Co-CIO Jeff Shen stays upbeat on U.S. stocks, sees opportunities abroad

Blackrock Co-CIO Jeff Shen stays upbeat on U.S. stocks, sees opportunities abroad

BlackRock’s Jeff Shen, remains constructive on U.S. equities over the next six-to-12 months, but he said investors may find more compelling opportunities overseas as global markets play catch-up. “There’s a fundamental capital expenditure story, given the excitement around artificial intelligence and the potential productivity growth coming from this investment,” said Shen, co-chief investment officer and…

Read More
FDA to speed up generic drug approvals as Trump targets drug costs

FDA to speed up generic drug approvals as Trump targets drug costs

U.S. Food and Drug Administration Commissioner Marty Makary speaks during a press conference alongside U.S. Secretary of Health and Human Services Robert F. Kennedy Jr., and Centers for Medicare & Medicaid Services Administrator Mehmet Oz, discussing administration plans to lower drug costs, at the Department of Health and Human Services in Washington, D.C., U.S., Oct….

Read More